当前位置:首页 - 行情中心 - 花园生物(300401) - 财务分析 - 现金流量表

花园生物

(300401)

  

流通市值:84.48亿  总市值:85.87亿
流通股本:5.35亿   总股本:5.43亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金324,725,343.851,266,881,515.03898,818,724.52606,935,317.41
收到的税费返还33,991,163.675,413,792.154,929,170.7145,584,946.09
收到其他与经营活动有关的现金31,720,518.06141,316,768.86124,524,642.5589,474,862.6
经营活动现金流入的平衡项目0000
经营活动现金流入小计390,437,025.511,483,612,075.991,078,272,537.78741,995,126.1
购买商品、接受劳务支付的现金86,964,161.4423,879,914.78349,338,545.49211,990,570.26
支付给职工以及为职工支付的现金57,934,625.18141,833,937.74110,467,759.2982,633,908.11
支付的各项税费56,232,560.73129,715,672.5595,888,536.883,773,410.11
支付其他与经营活动有关的现金45,249,413.52321,776,218.03250,778,845.41177,479,447.4
经营活动现金流出的平衡项目0000
经营活动现金流出小计246,380,760.831,017,205,743.1806,473,686.99555,877,335.88
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额144,056,264.68466,406,332.89271,798,850.79186,117,790.22
二、投资活动产生的现金流量:
收回投资收到的现金-1,712,000,1001,092,000,000760,000,000
取得投资收益收到的现金-716,902.823,175,609.571,709,304.11
处置固定资产、无形资产和其他长期资产收回的现金净额-29,308,654.419,076,877.4919,436,728.46
投资活动现金流入的平衡项目-000
投资活动现金流入小计-1,742,025,657.221,114,252,487.06781,146,032.57
购建固定资产、无形资产和其他长期资产支付的现金136,939,714.12480,378,960.37338,843,056.72224,886,387.07
投资支付的现金60,000,0001,945,331,7061,515,331,6061,153,331,606
支付其他与投资活动有关的现金-10,499,602.51--
投资活动现金流出的平衡项目0000
投资活动现金流出小计196,939,714.122,436,210,268.881,854,174,662.721,378,217,993.07
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-196,939,714.12-694,184,611.66-739,922,175.66-597,071,960.5
三、筹资活动产生的现金流量:
吸收投资收到的现金-0--
取得借款收到的现金149,100,0001,225,600,000945,600,000631,000,000
收到其他与筹资活动有关的现金-100,698,800101,540,300.44101,540,300
筹资活动现金流入平衡项目0000
筹资活动现金流入小计149,100,0001,326,298,8001,047,140,300.44732,540,300
偿还债务支付的现金320,000,0001,137,979,283.69813,270,000409,850,000
分配股利、利润或偿付利息支付的现金11,866,994.9767,393,217.4160,188,339.0853,363,329.87
支付其他与筹资活动有关的现金-13,268,910.8313,268,910.8313,268,910.83
筹资活动现金流出平衡项目0000
筹资活动现金流出小计331,866,994.971,218,641,411.93886,727,249.91476,482,240.7
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-182,766,994.97107,657,388.07160,413,050.53256,058,059.3
四、汇率变动对现金及现金等价物的影响2,640,603.614,150,6962,030,856.652,948,083.79
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-233,009,840.8-115,970,194.7-305,679,417.69-151,948,027.19
加:期初现金及现金等价物余额1,267,461,798.571,383,431,993.271,380,162,900.031,380,162,900.03
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,034,451,957.771,267,461,798.571,074,483,482.341,228,214,872.84
补充资料:
净利润-309,208,988.02-142,113,838.78
资产减值准备-2,505,142.09-382,792.75
固定资产和投资性房地产折旧-147,214,908.89-71,364,557.6
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-147,214,908.89-71,364,557.6
无形资产摊销-8,558,447.01-4,125,804.79
处置固定资产、无形资产和其他长期资产的损失--31,530,438.85--31,736,406.76
固定资产报废损失-270,194.18-19,173.22
公允价值变动损失--245,210.96--
财务费用-31,484,275.23-34,733,310.76
投资损失--716,902.82--313,047.8
递延所得税--4,181,569.05--1,149,516.18
其中:递延所得税资产减少-5,496,260.86-410,468.15
递延所得税负债增加--9,677,829.91--1,559,984.33
存货的减少--60,380,685.45--16,282,964.8
经营性应收项目的减少--35,699,277.61--1,000,913.1
经营性应付项目的增加-77,367,175.93--25,934,548.53
其他-20,512,358.42-9,795,709.49
现金的期末余额-1,267,461,798.57-1,228,214,872.84
减:现金的期初余额-1,383,431,993.27-1,380,162,900.03
公告日期2025-04-182025-03-252024-10-182024-08-24
审计意见(境内)标准无保留意见
TOP↑